Peplin

Latest Peplin news

news

09-June-09

Peplin Initiates Phase 3 Clinical Trials with PEP005 Gel in AK on Face and Scalp read more

28-May-09

Peplin's Positive Phase II AK Trial Results Published in JAAD read more

17-May-09

Positive Results for Peplin's First Phase III AK Trial read more

15-May-09

Peplin Results for the Quarter Ended 31 March 2009 read more

›› More News

Scientific Posters

Basic Science

Authors Title Reference
Ogbourne SM, Parsons P, Suhrbier A Novel Mechanism of Action Predicts Short Course of Therapy of PEP005 for Topical Applications click here to view poster Poster presented at the 21stWorld Congress of Dermatology, October 1 to 5, 2007, Buenos Aires, Argentina
Ogbourne SM, Parsons P, Challacombe J, Suhrbier A Mechanism of action of PEP005 for topical applications click here to view poster Poster presented at the Summer American Academy of Dermatology August 1 to 5, 2007, New York, New York, USA

Clinical

Authors Title Reference
 Berman B Discovery and development timeline of a novel treatment for actinic keratosis:  PEP005 (ingenol mebutate) Gel click here to view poster Poster presented at the South Beach Symposium February 13, 2009 in Miami, FL
Anderson L, Schmieder GJ, Werschler WP, Tschen EH, Ling MR, Stow DB, Katsamas J Safety and efficacy of ingenol mebutate (PEP005) gel, 0.025% and 0.05%, for actinic keratosis click here to view poster Poster presented at Summer Academy 08, American Academy of Dermatology meeting, July 30 to August 03, 08, Chicago, IL, USA
Anderson L, Schmieder GJ, Werschler WP, Tschen EH, Ling MR, Stow DB, Welburn, P Efficacy and tolerability of ingenol mebutate (PEP005) gel, 0.025% and 0.05%, for scalp and non-scalp actinic keratosis click here to view poster Poster presented at Summer Academy 08, American Academy of Dermatology meeting, July 30 to August03, 08, Chicago, IL, USA
Freeman M, Oakley A, Siller G, Rosen R, Salmon P, Spelman L, Shumack S, Rubel D, Birchall N, Katsamas K Study to determine the optimal tolerated regimen of ingenol mebutate (PEP005) gel for actinic keratosis of the face or face and scalp click here to view poster Poster presented at Summer Academy 08, American Academy of Dermatology meeting, July 30 to August 03, 08, Chicago, IL, USA
Rosen RH, Katsamas J, Ogbourne SM, Welburn P Early Phase Clinical Development of PEP005 Topical Gel for Basal Cell Carcinoma click here to view poster Poster presented at the 21st World Congress of Dermatology meeting, October 1 to 5, 2007, Buenos Aires, Argentina
Rosen RH, Freeman M, Siller G, Ogbourne SM Safety and Efficacy of PEP005 Topical Gel for the Treatment of Squamous Cell Carcinoma In Situ click here to view poster Poster presented at the 21stWorld Congress of Dermatology, October 1–5, 2007, Buenos Aires, Argentina
Anderson L, Welburn P Maximum tolerated dose of PEP005 Topical Gel for the treatment of actinic keratosis click here to view poster Poster presented at the Summer American Academy of Dermatology August 1 to 5, 2007, New York, New York, USA
Rosen RH, Freeman M, Siller G, Katsamas J, Ogbourne SM Safety and efficacy of PEP005 Topical Gel for the treatment of nodular and superficial forms of basal cell carcinoma click here to view poster Poster presented at the Summer American Academy of Dermatology August 1 to 5, 2007, New York, New York, USA
Welburn P, Dosik JS Skin sensitization potential of PEP005 Topical Gel click here to view poster Poster presented at the Summer American Academy of Dermatology August 1 to 5, 2007, New York, New York, USA
Anderson L, Katsamas J, Welburn P Early Phase Clinical Development of PEP005 Topical Gel for Actinic Keratoses click here to view poster Poster presented at the 21st World Congress of Dermatology, October 1–5, 2007, Buenos Aires, Argentina